This cost plus fixed fee task order is for coordinated facilities requirements for FY22 facilities BAS upgrade
Ended Awarded Last action
- Contract number
- 75N91022F00029
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,596,890
Award facts
- Contract value 100% obligated
- $3,596,890.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $3,596,890 |
About this award
This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The task order is for coordinated facilities requirements in support of the FY22 facilities BAS (Building Automation Systems) upgrade at the Fort Detrick location in Maryland. The task order has a completion date of July 20, 2026 and a potential value of $3,596,890.00. Leidos Biomedical Research, as an FFRDC (Federally Funded Research and Development Center) contractor for the NCI, has a broad contract to provide biomedical research and facilities support services. This specific task order falls under that larger contract vehicle. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91022F00029?
75N91022F00029 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 23, 2022.
How much is contract 75N91022F00029 worth?
The government has obligated $3,596,890 on 75N91022F00029.
Is contract 75N91022F00029 an order under another contract?
Yes. 75N91022F00029 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91022F00029 competed?
The extent of competition for 75N91022F00029 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award